QSAR, molecular docking and ADMET properties in silico studies of novel 4,5,6,7-tetrahydrobenzo[D]-thiazol-2-Yl derivatives derived from dimedone as potent anti-tumor agents throug... by Ossama Daoui, Souad Elkhattabi, Samir Chtita, Rachida Elkhalabi, Hsaine Zgou, Adil Touimi Benjelloun

Subjects: “…C-Met inhibitors…”
Get full text

Design, Synthesis, and Evaluation of New Mesenchymal–Epithelial Transition Factor (c-Met) Kinase Inhibitors with Dual Chiral Centers by Han Yao, Yuanyuan Ren, Jun Yan, Jiadai Liu, Jinhui Hu, Ming Yan, Xingshu Li

Subjects: “…c-Met inhibitors…”
Get full text

Design, synthesis, and biological evaluation of thiazole/thiadiazole carboxamide scaffold-based derivatives as potential c-Met kinase inhibitors for cancer treatment by Xiang Nan, Qiu-Xu Wang, Shao-Jun Xing, Zhi-Gang Liang

Subjects: Get full text

Research Progress of Small Molecule VEGFR/c-Met Inhibitors as Anticancer Agents (2016–Present) by Qian Zhang, Pengwu Zheng, Wufu Zhu

Subjects: “…dual VEGFR/c-Met inhibitors…”
Get full text

Targeting c-Met in breast cancer: From mechanisms of chemoresistance to novel therapeutic strategies by Emeka Eze Joshua Iweala, Doris Nnenna Amuji, Abimbola Mary Oluwajembola, Eziuche Amadike Ugbogu

Subjects: Get full text

Phase I/II study of c-MET inhibitor (DE605) combined with sorafenib in patients with advanced hepatocellular carcinoma by Bahar Karayel, Sena Durgun, Orhan Öcalgiray

Subjects: “…c-MET inhibitor…”
Get full text

Effect of Food on the Pharmacokinetics and Safety of a Novel c-Met Inhibitor SCC244: A Randomized Phase I Study in Healthy Subjects by Wu J, Xu H, Li H, Ma L, Chen J, Yuan F, Sheng L, Liu C, Chen W, Li X

Subjects: Get full text

Design, Synthesis and Antitumor Activity of Novel Selenium-Containing Tepotinib Derivatives as Dual Inhibitors of c-Met and TrxR by Jinhui Hu, Li Chen, Zhonghui Lu, Han Yao, Yunfei Hu, Luanqi Feng, Yanqing Pang, Jia-Qiang Wu, Zhiling Yu, Wen-Hua Chen

Subjects: Get full text

Design, Synthesis, and Biological Evaluation of [1,2,4]triazolo[4,3-a] Pyrazine Derivatives as Novel Dual c-Met/VEGFR-2 Inhibitors by Xiaobo Liu, Xiaobo Liu, Yuzhen Li, Qian Zhang, Qingshan Pan, Pengwu Zheng, Xinyang Dai, Zhaoshi Bai, Wufu Zhu

Subjects: “…c-Met inhibitor…”
Get full text

Synthesis, Evaluation, and Mechanism Study of New Tepotinib Derivatives as Antiproliferative Agents by Niu-niu Zhang, Bai-jiao An, Yan Zhou, Xing-shu Li, Ming Yan

Subjects: Get full text

Phase 1 Study of the Selective c-MET Inhibitor, HS-10241, in Patients With Advanced Solid Tumors by Xiaorong Dong, MD, PhD, Xingya Li, MD, Jianhua Chen, MD, Shenglin Ma, MD, Deguang Mu, MD, Jie Hu, MD, PhD, Shun Lu, MD

Subjects: “…c-Met inhibitor…”
Get full text

Clinical Development of c-MET Inhibition in Hepatocellular Carcinoma by Joycelyn J. X. Lee, Jack J. Chan, Su Pin Choo

Subjects: Get full text

Combination therapy with c-met inhibitor and TRAIL enhances apoptosis in dedifferentiated liposarcoma patient-derived cells by Eun Byeol Jo, Young Sang Lee, Hyunjoo Lee, Jae Berm Park, Hyojun Park, Yoon-La Choi, Doopyo Hong, Sung Joo Kim

Subjects: Get full text